- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產(chǎn)品
- 聯(lián)系我們
別名: MK 8628 中文名稱:比拉瑞塞
Birabresib (OTX015, MK 8628) 是一種有效的BET bromodomain抑制劑,在無細胞試驗中對BRD2,BRD3,和BRD4的EC50范圍為10 到 19 nM。Birabresib 可抑制 Nuclear receptor binding SET domain protein 3 (NSD3) 的靶基因表達。
Birabresib (OTX015) Chemical Structure
CAS: 202590-98-5
細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息 |
---|---|---|---|---|---|
MV4-11 | Cell cycle assay | 125 nM | 24 hrs | Cell cycle arrest in human MV4-11 cells assessed as increase in accumulation at G1-phase at 125 nM measured after 24 hrs by propidium iodide staining based flow cytometry | 32208600 |
MV4-11 | Function assay | 500 nM | 6 to 24 hrs | Inhibition of BRD4 in human MV4-11 cells assessed as reduction in c-Myc expression at 500 nM measured after 6 to 24 hrs by Western blot analysis | 32208600 |
MV4-11 | Function assay | 31.25 to 125 nM | 6 hrs | Inhibition of BRD4 in human MV4-11 cells assessed as reduction in c-Myc mRNA level at 31.25 to 125 nM measured after 6 hrs by SYBR green dye based RT-qPCR analysis | 32208600 |
MV4-11 | Function assay | 31.25 to 125 nM | 6 hrs | Inhibition of BRD4 in human MV4-11 cells assessed as reduction in BCL2 mRNA level at 31.25 to 125 nM measured after 6 hrs by SYBR green dye based RT-qPCR analysis | 32208600 |
MV4-11 | Function assay | 31.25 to 125 nM | 6 hrs | Inhibition of BRD4 in human MV4-11 cells assessed as reduction in CDK6 mRNA level at 31.25 to 125 nM measured after 6 hrs by SYBR green dye based RT-qPCR analysis | 32208600 |
MV4-11 | Function assay | 10 to 100 nM | 24 hrs | Inhibition of BRD4 in human MV4-11 cells assessed as reduction in c-Myc mRNA level at 10 to 100 nM after 24 hrs by real time qPCR analysis | 31490070 |
RKO | Cell cycle assay | 100 nM | 24 hrs | Induction of cell cycle arrest in human RKO cells assessed as increase in accumulation at G1 phase at 100 nM after 24 hrs by propidium iodide staining based flow cytometric analysis | 31490070 |
Rosetta2 DE3 | Function assay | 30 mins | Displacement of FAM-labeled ZBA248 from BRD3 BD2 (306 to 417 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay, Ki=0.004μM. | 26080064 | |
Rosetta2 DE3 | Function assay | 30 mins | Displacement of FAM-labeled ZBA248 from BRD2 BD2 (349 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay, Ki=0.0054μM. | 26080064 | |
Rosetta2 DE3 | Function assay | 30 mins | Displacement of FAM-labeled ZBA248 from BRD4 BD2 (333 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay, Ki=0.006μM. | 26080064 | |
MM1S | Antiproliferative assay | 72 hrs | Antiproliferative activity against human MM1S cells after 72 hrs by CCK8 or SRB assay, IC50=0.0063μM. | 31490070 | |
Rosetta2 DE3 | Function assay | 30 mins | Displacement of FAM-labeled ZBA248 from BRD3 BD1 (24 to 144 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay, Ki=0.0107μM. | 26080064 | |
Rosetta2 DE3 | Function assay | 30 mins | Displacement of FAM-labeled ZBA248 from BRD4 BD1 (44 to 168 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay, Ki=0.0109μM. | 26080064 | |
Rosetta2 DE3 | Function assay | 30 mins | Displacement of FAM-labeled ZBA248 from BRD2 BD1 (72 to 205 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay, Ki=0.0166μM. | 26080064 | |
Rosetta2 DE3 | Function assay | 30 mins | Displacement of FAM-labeled ZBA248 from BRD4 BD2 (333 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay, IC50=0.0166μM. | 26080064 | |
MV4-11 | Antiproliferative assay | 4 days | Antiproliferative activity against human MV4-11 cells assessed as cell growth inhibition after 4 days by CCK8 assay, IC50=0.0176μM. | 31461688 | |
MM1S | Antiproliferative assay | 4 days | Antiproliferative activity against human MM1S cells assessed as cell growth inhibition after 4 days by CCK8 assay, IC50=0.0227μM. | 31461688 | |
Rosetta2 DE3 | Function assay | 30 mins | Displacement of FAM-labeled ZBA248 from BRD4 BD1 (44 to 168 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay, IC50=0.0255μM. | 26080064 | |
BL21(DE3) | Function assay | 4 hrs | Displacement of 5-FITC labelled (+)-JQ1 from His6-tagged human BRD4 bromodomain 1 expressed in Escherichia coli BL21(DE3) )-codon plus-RIL cells incubated for 4 hrs in dark condition by fluorescence anisotropy binding assay, IC50=0.0343μM. | 31490070 | |
MV4-11 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human MV4-11 cells assessed as reduction in cell viability measured after 72 hrs by Celltitre-glo luminescence assay, IC50=0.0463μM. | 32208600 | |
Kasumi-1 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human Kasumi-1 cells assessed as reduction in cell viability measured after 72 hrs by Celltitre-glo luminescence assay, IC50=0.135μM. | 32208600 | |
MM1S | Antiproliferative assay | 72 hrs | Antiproliferative activity against human MM1S cells assessed as reduction in cell viability measured after 72 hrs by Celltitre-glo luminescence assay, IC50=0.137μM. | 32208600 | |
RS4:11 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human RS4:11 cells assessed as reduction in cell viability measured after 72 hrs by Celltitre-glo luminescence assay, IC50=0.416μM. | 32208600 | |
TY82 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human TY82 cells after 72 hrs by CCK8 or SRB assay | 31490070 | |
MV4-11 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human MV4-11 cells after 72 hrs by CCK8 or SRB assay | 31490070 | |
MV4-11 | Apoptosis assay | 24 hrs | Induction of apoptosis in human MV4-11 cells after 24 hrs by Annexin V staining based assay | 31490070 | |
THP1 | Antiproliferative assay | Antiproliferative activity against human THP1 cells, IC50=0.033μM. | 28939121 | ||
TY82 | Antiproliferative assay | Antiproliferative activity against human TY82 cells, IC50=0.067μM. | 28939121 | ||
insect cells | Function assay | Inhibition of recombinant full length human N-terminal His6-tagged BRD4 (2 to 1362 residues) expressed in baculovirus infected insect cells using histone H4 peptide as substrate by alpha screen assay, IC50=0.092μM. | 30529546 | ||
LNCAP | Antiproliferative assay | Antiproliferative activity against human LNCAP cells, IC50=0.1114μM. | 29758518 | ||
點擊查看更多細胞系數(shù)據(jù) |
產(chǎn)品描述 | Birabresib (OTX015, MK 8628) 是一種有效的BET bromodomain抑制劑,在無細胞試驗中對BRD2,BRD3,和BRD4的EC50范圍為10 到 19 nM。Birabresib 可抑制 Nuclear receptor binding SET domain protein 3 (NSD3) 的靶基因表達。 | ||
---|---|---|---|
特性 | 口服生物可利用的BRD2/3/4選擇性抑制劑,處于臨床I期臨床試驗,用于治療血液學惡性腫瘤。 | ||
靶點 |
|
體外研究(In Vitro) | ||||
體外研究活性 | OTX015抑制BRD2,BRD3,和BRD4與AcH4的結(jié)合,IC50的范圍為92到112 nM,并抑制各種人癌細胞系的生長,GI50的范圍為60到200 nM。[1] OTX015導致c-MYC表達快速下調(diào),并且在ALKpos ALCL細胞系中,表現(xiàn)出與ALK抑制劑結(jié)合的協(xié)同抗增殖作用。[2] | |||
---|---|---|---|---|
激酶實驗 | TR-FRET 試驗[1] | |||
為了評估OTX015與BRD2,BRD3,以及BRD4的結(jié)合,BRD表達的CHO細胞裂解物(來自感染表達質(zhì)粒的CHO細胞, Flag標記的BRD2,BRD3,或BRD4 或僅載體),銪共軛的抗Flag抗體,XL-665共軛的鏈霉親和素,和生物素化的OTX015在室溫下培育0.2到2小時。熒光性通過TR-FRET使用EnVision 2103多標閱讀器測量,結(jié)合的EC50使用5.02版PRISM通過非線性回歸計算。 | ||||
細胞實驗 | 細胞系 | 人腫瘤細胞 | ||
濃度 | ~2 μM | |||
孵育時間 | 72小時 | |||
方法 | OTX015對癌細胞增殖的作用通過將人腫瘤細胞在逐漸增加濃度的OTX015下培育72小時進行評估,并使用基于四唑鹽(WST-8)的比色測定評估。 |
|||
實驗圖片 | 檢測方法 | 檢測指標 | 實驗圖片 | PMID |
Western blot |
BRD4
c-Myc
感谢您访问我们的网站,您可能还对以下资源感兴趣: 天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口 |